Dow Jones soars above 23,000. Is it too stretched? >>> READ MORE

Inovio Pharmaceuticals Announces 1-4 Reverse Split for INO Stock

It has not said when the split will take effect


On Friday, Inovio Pharmaceuticals (INO) announced that its shareholders had approved 1-for-4 reverse stock split of Inovio common stock. INO shares sank more than 5% in morning trading.

inovio 185Inovio said that the effective date of the reverse stock split would be disclosed at a future date after Inovio complies with “standard NYSE administrative processes.”

In a statement, Inovio President and CEO Dr. J. Joseph Kim said: “Our stockholders approved a reverse split to have our price and share structure reflect our leadership position in immunotherapies and expand our potential investor audience.”

Inovio is developing vaccines against HPV-caused pre-cancers and cancers, prostate, breast, and lung cancers, and HIV, influenza, malaria and hepatitis.

More Pharma Stock News:

Article printed from InvestorPlace Media,

©2017 InvestorPlace Media, LLC